Methylation of Interleukin-1 receptor-associated kinase-3 and the risk of multiple sclerosis relapse/activity
Clinical Immunology · 2024-09 · 266 · 110327
DOI: 10.1016/j.clim.2024.110327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Immunology, 2024-09. Verfasst von Mona M Watany und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical pathology department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt. Electronic address: mona.watany@med.tanta.edu.eg. Hauptthemen laut MEDLINE: Interleukin-1 Receptor-Associated Kinases, Multiple Sclerosis, Myeloid Differentiation Factor 88. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
This study retrospectively investigated the impact of interleukin-1 receptor-associated kinase-3 (IRAK-3/IRAK-M) silencing by methylation on the likelihood of multiple sclerosis (MS) activity. This cross-sectional study included 90 patients with MS: 45 with active disease (Group 1), 45 in remission (Group 2), and 45 healthy controls. The study included quantitation of IRAK-3 methylation index (MI%), IRAK-3 mRNA, and myeloid differentiation factor88 (MyD88) and assessment of NF-κB activity. IRAK-3 MI% was significantly higher in group 1 compared to group 2, accompanied by lower IRAK-3 mRNA expression, elevated circulating MyD88, and increased NF-κB activity. IRAK-3 MI% correlated negatively with its transcript and positively with MyD88 and NF-κB activity. A logistic regression model was created to predict active demyelination. The C-index was 0.924, which indicates a very strong prediction model. Within the limitations of current work, IRAK-3 methylation level seems to be a promising candidate biomarker for identifying MS patients at risk of relapse.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical pathology department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt. Electronic address: mona.watany@med.tanta.edu.eg.
- Msc Immunology from Tanta university, Faculty of Science, Tanta 31527, Egypt.
- Medical biochemistry department, Faculty of Medicine. Tanta University, Tanta 31527, Egypt; Biochemistry Department, College of Medicine, Ha'il University, Ha'il 55211, Saudi Arabia.
- Neurology department, Faculty of Medicine. Tanta University, Tanta 31527, Egypt.
Zitieren
APA
Watany, M. M., Elhosary, M. M., El-Horany, H. E., & El-Horany, M. E. (2024). Methylation of Interleukin-1 receptor-associated kinase-3 and the risk of multiple sclerosis relapse/activity. Clinical Immunology, 266, 110327. https://doi.org/10.1016/j.clim.2024.110327
Vancouver
Watany MM, Elhosary MM, El-Horany HE, El-Horany ME. Methylation of Interleukin-1 receptor-associated kinase-3 and the risk of multiple sclerosis relapse/activity. Clinical Immunology. 2024;266:110327. doi:10.1016/j.clim.2024.110327
BibTeX
@article{Watany2024,
author = {Watany, Mona M and Elhosary, Marwa M and El-Horany, Hemat E and El-Horany, Mahmoud E},
title = {Methylation of Interleukin-1 receptor-associated kinase-3 and the risk of multiple sclerosis relapse/activity},
journal = {Clinical Immunology},
year = {2024},
volume = {266},
pages = {110327},
doi = {10.1016/j.clim.2024.110327}
}
EUVIMED